Operative Outcomes of Metabolic/Bariatric Surgery in Subjects with Type 1 Obesity Index (30–35 kg/m2)
The body mass index (BMI) was developed as an objective and easy method to measure obesity, and it became a useful tool for population and epidemiological studies. BMI was quickly adopted as the main criterion for bariatric surgery, with a “cutoff” value of 35–40 kg/m2, depending on the patients’ comorbidities. However, by ignoring other parameters such as race, gender, age, and fat distribution, this arbitrary system excluded many patients who could benefit from this lifesaving treatment. In addition, there is increasing evidence that bariatric/metabolic surgery in patients with BMI from 30 kg/m2 may have a positive effect on medically uncontrolled type 2 diabetes mellitus (T2DM) as well as other comorbidities. Hence, this provides a strong argument for performing bariatric/metabolic surgery in patients with lower BMI. This chapter identifies the main pitfalls of the present BMI-centered inclusion criteria for bariatric surgery, justifies the need for bariatric/metabolic surgery in patients regardless of baseline BMI, and determines the efficacy and safety of bariatric procedures in those patients.
KeywordsObesity Type 2 diabetes mellitus Metabolic surgery Bariatric surgery
- 3.American Diabetes Association Standards of Medical Care in Diabetes. Diabetes Care. 2017;40(Suppl. 1):S1–2.Google Scholar
- 7.le Roux CW, Aylwin SJ, Batterham RL, et al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg. 2006;243(1):108–14. https://doi.org/10.1097/01.sla.0000183349.16877.84.CrossRefPubMedGoogle Scholar
- 11.Peterli R, Wölnerhanssen BK, Peters T, Vetter D, Kröll D, Borbély Y, Schultes B, Beglinger C, Drewe J, Schiesser M, Nett P, Bueter M. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity: the SM-BOSS randomized clinical trial. JAMA. 2018;319(3):255–65.CrossRefGoogle Scholar
- 32.Cohen R, Caravatto PP, Correa JL, et al. Glycemic control after stomach-sparing duodenal-jejunal bypass surgery in diabetic patients with low body mass index. SOARD. 2012;8(4):375–80.Google Scholar
- 34.Ramos AC, Neto MG, de Souza YM, Galvão M. Laparoscopic duodenal–jejunal exclusion in the treatment of type 2 diabetes mellitus in patients with BMI. Obes Surg 2009 <30 kg/m2 (LBMI). 19(3):307–12.Google Scholar